ISIN | CH0104078727 |
---|---|
Valor Number | 10407872 |
Bloomberg Global ID | |
Fund Name | Schroder Swiss Equity Core Fund I |
Fund Provider |
Schroder Investment Management (Switzerland) AG (LUX & CH)
Zurich/Geneva, Switzerland Web: https://www.schroders.com/en/ch/asset-management/ Phone: +41 (0) 800 844 448 E-Mail: info-sim@schroders.com |
Fund Provider | Schroder Investment Management (Switzerland) AG (LUX & CH) |
Representative in Switzerland | |
Distributor(s) |
Schroder & Co Bank AG Zürich Phone: +41 44 250 11 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Schroder Swiss Equity Core Fund is an open-end fund incorporated in Switzerland. The Fund's objective is to obtain long-term capital growth. The Fund is actively managed and tries to exceeds the performance of Swiss Performance Index (SPI). |
Peculiarities |
Current Price * | 288.91 CHF | 09.10.2025 |
---|---|---|
Previous Price * | 289.56 CHF | 08.10.2025 |
52 Week High * | 294.33 CHF | 03.03.2025 |
52 Week Low * | 245.51 CHF | 09.04.2025 |
NAV * | 288.91 CHF | 09.10.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | ||
Unit/Share Assets *** | 14,559,557 | |
Trading Information SIX |
YTD Performance | +10.28% |
30.12.2024 - 09.10.2025
30.12.2024 09.10.2025 |
---|---|---|
1 month | +0.70% |
09.09.2025 - 09.10.2025
09.09.2025 09.10.2025 |
3 months | +2.07% |
09.07.2025 - 09.10.2025
09.07.2025 09.10.2025 |
6 months | +17.68% |
09.04.2025 - 09.10.2025
09.04.2025 09.10.2025 |
1 year | +5.08% |
09.10.2024 - 09.10.2025
09.10.2024 09.10.2025 |
2 years | +19.99% |
09.10.2023 - 09.10.2025
09.10.2023 09.10.2025 |
3 years | +30.88% |
10.10.2022 - 09.10.2025
10.10.2022 09.10.2025 |
5 years | +32.36% |
09.10.2020 - 09.10.2025
09.10.2020 09.10.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 12.23% | |
---|---|---|
Roche Holding AG | 11.35% | |
Nestle SA | 10.68% | |
Compagnie Financiere Richemont SA Class A | 5.78% | |
Zurich Insurance Group AG | 5.05% | |
UBS Group AG Registered Shares | 4.06% | |
ABB Ltd | 3.50% | |
Partners Group Holding AG | 2.84% | |
Sandoz Group AG Registered Shares | 2.76% | |
Alcon Inc | 2.24% | |
Last data update | 30.09.2025 |
TER | 0.09% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.09% |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |